Introduction
Publications in 1966 indicated the continued search for new and better antimicrobic drugs, but also emphasized many harmful effects from their logical application and especially from their indiscriminate use. Alarm again was raised about the increasing incidence of nosocomial and iatrogenic infections caused by antimicrobic-resistant Gramnegative bacilli, by latent viruses and fungi. More facts accrued about the multitropism of viruses usually regarded as selective of one tissue or organ. Progress was made in the preparation of vaccines against a number of viral diseases and antiviral chemical agents for their prevention and treatment are under investigation. The aetiologic relation of viruses to cancer and lymphomas in man remains unclear. The Asian epidemic of cholera provided opportunity for extensive investigation. War in south-eastern Asia induced a resurgence of interest in exotic infections.
Antimicrobic agents
The indiscriminate application of antimicrobics continues. An investigation in eighteen hospitals disclosed that 26% of patients received antibiotics, in one instance 40%. Patients in a 500-bed hospital paid $20,000 (£6944) in 1 acetanilid and phenacetin, now known to be dangerous, were and still are widely used for treatment.2 Because bodily temperature higher than the norm is unfavourable to viruses, antipyretic drugs rarely should be prescribed for fever.
Reports of the failure of antimicrobic prophylaxis for surgical wound infections continue to appear,3 but seem to be generally unheeded. No differences accrued in the number of postoperative infections among 150 surgical patients whether or not patients received methicillin or chloramphenicol. 4 The same applies to prophylaxis for extensive burns. 5 In a 5-year study, British observers found little benefit either prophylactically or therapeutically from the administration of antimicrobics to victims of chronic bronchitis.6 This is not surprising if viruses often are causes. In one study of fifteen patients for 2 years, seventy-five periods of illness were associated with viruses, 23% of which were rhinoviruses.7 'Anticold' nostrums that contain antimicrobics were suppressed by the U.S. Federal Drug Administration. 8 A useful outline of measures used to select appropriate antimicrobics, the manner of their application and precautions against adverse reactions was published.9 If it is adopted much needless therapy would be avoided.
New antimicrobics
Among newly introduced antimicrobics are ferrimycin, verrucarin, moenomycin, kasugamycin, sugordomycin,10 hetacillin, doxycycline, hedamycin, leucomycin, rifamycin, rondomycin, garamycin, hamycin and lysostaphin.11 One wonders how many are different and superior to ones now in use, and which ones will survive the test of time. Several authorities doubt that those now at hand will be superseded. The bewildering number of antimicrobics makes it difficult for a physician to decide which one to use for what infection, how much to use and how.
Ampicillin is bactericidal and resembles cephalothin and tetracycline in its effects. It 15 For several reasons, including its greater action against gonococci,16 cephaloridin is superior to cephalothin. 17 It was effective against all Grampositive coccal infections, excepting enterococci, against penicillin-resistant staphylococci, most strains of coliforms and some strains of Proteus. Large dosage was nephrotoxic.18, 19 Cephalothin may cause allergic reactions in patients sensitive to penicillins. 20, 21 Cephalosporin cured endocarditis in penicillin-sensitive patients. 22 Kanamycin attacks Gram-negative bacilli excepting Pseudomonas, and is useful for tuberculosis that resists other agents. Some staphylococci have become resistant. Thirty tons of kanamycin were used in 8 years, but it is being supplanted by semisynthetic penicillins.23 Gentamycin is bactericidal and more active than streptomycin and kanamycin against Pseudomonas and also is active against neomycin-, bacitracinand kanamycin-resistant staphylococci. 24 Penicillin, erythromycin, ampicillin and lincomycin were equally effective in the treatment of haemolytic streptococcal infections in children and in eliminating cocci from the throat. Ten to 30 days after therapy, recurrent infection or the carrier state ensued in about 20% of patients.25 Drugs of choice for E. coli infections are ampicillin and tetracycline; for nonmotile Klebsiella, cephalothin and kanamycin; for motile Aerobacter, kanamycin and chloramphenicol; for Proteus mirabilis, ampicillin and kanamycin; for indole-positive Proteus, kanamycin; and for Pseudomonas, colistin and polymyxin B.26 According to Foster's advice, kanamycin or neomycin is best for E. coli infections; tetracycline or chloramphenicol for Aerobacter and neomycin or kanamycin for resistant Proteus.27 Evidently, at present, opinions differ.
Candicin, whose antifungal spectrum resembles amphotericin B, was effective in the treatment of candidal vaginitis and tolfanate for the treatment of cutaneous infections.28
At the December conference arranged by the New York Academy of Sciences, ampicillin was said to increase more slowly, attain a lower level, and persist longer in the blood than penicillin because of lesser renal excretion. Ampicillin changes to hetacillin in vivo and neither are effective against coliforms, aerobic streptococci or Bacteroides. Ampicillin is as effective as chloramphenicol for typhoid and is of value in treating enterococcal endocarditis, meningococcal meningitis and shigellosis. Hetacillin cured pneumococcal pneumonia, but was ineffective for Klebsiella, Pseudomonas and penicillinase-producing staphylococci. Ampicillin, cephalothin and cephaloridine were of equal value for urinary tract infections. Kanamycin, though toxic, probably is the best single drug for Gram-negative bacillary infections. Lincomycin was not mentioned. Corticosteroid therapy is of doubtful value for the treatment of shock in Gram-negative bacillary sepsis.
Unwanted effects of antimicrobics
Reactions to drugs occurred in about 11% of patients in a hospital. 29 Elsewhere, 20% of patients had iatrogenic disease either from therapy or diagnostic procedures. Pseudomonas infections followed the use of cephalothin and Klebsiella infections occurred after therapy with ampicillin. In a 10-year period, 109 instances of staphylococcal enteritis occurred among patients who received antimicrobics prophylactically, chiefly chloramphenicol, during abdominal surgery. Vancomycin given orally was recommended for its treatment.30 Despite the use of antimicrobics or because they were used, the incidence of bacterial infections of the newborn increased in a hospital. The predominant causes were Gram-negative bacilli.31 Gram-negative bacillary septicemia increased seven-fold in a decade in Cincinnati hospitals, mostly in children and in persons more than 60 years old. The death-rate was 67%. Elsewhere the incidence of Gram-negative bacillary pneumonias, as found post-mortem, rose from 0-8% in 1952 to 7-9% in 1963. The increase was attributed to antimicrobic therapy and contaminated apparatuses for inhalation therapy, especially in debilitated patients.32 Candidiasis also has increased in incidence from the use of antimicrobics. 33 About 8% of patients treated with penicillin reacted adversely to it and from 100 to 300 deaths from anaphylaxis occur yearly in the United States.21' 29 Antibody to penicillin appeared in the blood in 1-8% of patients treated with the drug. Huge doses caused haemolytic anaemia in several instances34 and severe neural disturbances in others. 35 Elsewhere, the infection occurred throughout the year, but especially in the summer and seldom was severe in children.92
In another study, M. pharyngis and M. salivarium present in 50% of pneumonic patients were not causal. M. pneumoniae was recovered in 9-20% of patients and accounted for 13-50% of non-pneumococcal pneumonias. The cold agglutinin test was not discriminative in diagnosis.93
Nor was it of diagnostic value among 444 children with respiratory tract infections. In 28%, the test gave a positive result without other evidence of mycoplasmal infection.94
An antigenic formalin-killed vaccine was prepared and recommended for use because of the severity and duration of the infection. The increasing number of immunizing agents raises questions as to which ones really are effective, how many a person should receive alone or combined, which ones to use, when and how, and if any harm ensues. At present, agents are available against smallpox, poliomyelitis, measles, yellow fever, influenza, adenoviruses and rabies, typhoid, cholera, tuberculosis, pertussis, plague, pneumococcosis, tetanus and diphtheria. Under investigation are vaccines for RS, mumps, parainfluenza, rhinovirus, rubella and Japanese B viruses, mycoplasma, Q fever, streptococcosis, tularaemia, anthrax and others. The status of vaccines incorporated with adjuvants to increase their potency was reviewed by Hilleman.132 The possibility that adenoviruses may be oncogenic has precluded the use of these live virus vaccines. If they do cause cancer, then properly prepared vaccines should not only prevent adenoviral respiratory tract infections safely, but also prevent the resultant cancers and their metastases after excision of the primary site. 133 
Chemotherapy of viral infections
Thiosemicarbazone for the treatment of smallpox has not fulfilled its early promise. Given prophylactically, it reduced the incidence of infection slightly, but not the fatality rate. It was not recommended for routine use.134 IDU (5-iododeoxyuridine) for prevention will be tested in India. Tetracycline given prophylactically after instrumention of the urinary tract did not reduce the incidence of bacteriuria. Many such infections are self-limiting and need no therapy. 244 Tetracycline effectively sterilized the urine of rats with pyelonephritis induced by E. coli, but infection persisted in the kidneys of 78%. The addition of streptomycin was not helpful. Ampicillin and penicillin were less effective. Evidently, renal infection may persist after the urine is cleared of bacteria.245
Coccal infections
In one study, the home not the school was the major locus of haemolytic streptococcal infections and the source of spread to a community. 246 Among 8000 cultures from the nose and throat of patients less than 18 years old, group A haemolytic streptococci were present in only 6-4%, and in 15% of children with exudative tonsillitis.247
Renal lesions after haemolytic streptococcal infection are not as benign as previously believed. According to biopsy evidence, about one-third of patients had renal abnormalities afterward.248 In another study, in six of twenty-one patients, biopsy and electron microscopy 20 months later disclosed changes in the mesangium. In ten others the residual changes were less severe. Staphylococci may become antimicrobic resistant in the body by transduction from resistant strains. Such genetic transmission of resistance probably occurred in addition to selection of resistant strains even before the general use of antimicrobics. 254 Sixty-one per cent of septicaemias among 512 patients occurred in infants and in old age. About half of the aged victims had chronic debilitating diseases. Staphylococci and Gram-negative bacilli were the chief causes. The incidence of septicaemia has increased since 1955 mostly caused by infection with Gram-negative bacilli, the mortalityrate of which remains the same, while that of staphylococcal septicaemias has diminished. 255 The death-rate from bacterial pneumonias declined from seventy to twenty-five per 100,000 between 1940 and 1950. The rate has not changed much to date and ranged between twenty per 100,000 in 1954, the lowest, to twenty-eight per 100,000 in 1957, 1960 and 1963. About 60,000 deaths from pneumonia occur annually in the United States, mostly in infants and in old age. 256 So far, eighteen instances of pneumonia caused by tetracycline-resistant pneumococci of Types 6, 7, 9, 11 and 14 were observed, mostly in persons older than 60 years. One patient with Type 14 infection died during treatment with tetracycline. 257 Gram-negative bacilli caused 3-7% of 'primary' pneumonias in a hospital. In 
